About Us

Our Mission

PANDAS Network is dedicated to improving the diagnosis and treatment of children with PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections) and PANS (Pediatric Acute-Onset Neuropsychiatric Syndrome). Armed with an impressive network of doctors, researchers and scientists, PANDAS Network builds public awareness, provides critical support for families and gathers data and resources to better inform parents and the medical community about these devastating and commonly misunderstood disorders. 

Our Values

PANDAS Network values the complex needs of families, physicians and researchers. We are:

  • Committed to supporting innovative research within the emergent field of neuro-psycho-immunology.
  • Dedicated to the empowerment of stakeholders through consistent sharing of research, clinical practices and real-life outcomes.
  • Driven to dramatically improve public and medical policy that allows for greater access to financial, psychological and medical resources.

Our History

Founder Diana Pohlman’s son Garrett was a happy and healthy 7-year-old when he experienced a few bouts of strep throat. He suddenly began to display frightening behaviors. After one year, his doctors determined that Garrett had PANDAS. The support of one parent and one doctor who believed in early PANDAS research allowed her lifesaving treatment for her son. Four years later, her younger daughter, age 6, also developed PANDAS. Advocating for lifesaving immunomodulation therapy stopped symptoms in both children, Diana recognized a gap in using available medical knowledge to quickly and effectively diagnose patients with PANDAS/PANS.  



A handful of supportive parents and doctors launched PANDAS Network to make sure that no parent would have to endure this illness alone. By the end of 2009, more than 600 families had called our founder as word of mouth spread. 


Dr. Susan Swedo and Dr. James Leckman, Psychiatry, Yale Child Studies Center, convened at a meeting of 50 experts at a National Institute of Mental Health conference to discuss the study of PANDAS. The result was the coining of a new term, PANS, that widened the potential triggers beyond strep infections.


By 2013, the demand for more doctors and awareness of the illness had grown nationally, and we formed a strong board of directors, all of whom are parents whose children have been affected by PANDAS/PANS.


Today, PANDAS Network holds an annual conference to discuss progress in the diagnosis and treatment of PANDAS/PANS. These events educate more than 300 physicians every year. Our groups have written medical studies, conducted surveys, called legislators and been on many media networks in hopes of awakening the need for early diagnosis and covered medical treatment.

Our Survey

Discover the latest information from our landmark PANDAS Network 2018 State of Our Children Survey.

Our Impact

Since 2009, PANDAS Network has improved public awareness of PANDAS/PANS onset and course of illness by providing medically accurate and scientifically reviewed information to families, patients and providers. We maintain a database of new PANDAS/PANS cases, refer parents to support groups and physicians and publish online newsletters about the latest research.

Impact by the Numbers

  • $2.2 million raised to support research and resources
  • 24,000+ PANDAS/PANS patients and caregivers served
  • 48 states have participated in October 9th awareness events
  • $640,000 in new investigative research awards


  • Giftedness Analysis Research of PANDA PANS Children (Dr. Denise Calaprice) $1,000
  • Stem Cell Research of PANDAS PANS children (Scintillon Institute, San Diego) $20,000


  • The Role of Regulatory T cells in Pediatrics Acute Onset Neuropsychiatric Syndrome (PANS): with an emphasis on CD39 cell (Dr. Noor Hussein, Stanford School of Medicine) $50,000
  • Genetic Research (Dr U. Akcan, Columbia) $50,000
  • Research (Dr. S. Patel, Sydney Children’s Hospital-AustraliaD.) $50,000


  • PANS Antibody Research (Dr. Cunningham, University of Oklahoma) $20,981
  • Brain Bank Equipment (Georgetown University) $2,000
  • Young Adult Survey (Dr. D. Calaprice Consulting) $11,000


  • Genetic Investigation PANDAS Relapse Focus (Dr. D. Agalliu, Columbia) $40,000
  • Gut Microbiome and Auto-antibody Identification (Dr. P. Kiela, University of Arizona) $53,000
  • Tonsil Study and Immune Cells Microbiome (Dr. E. Harley, Georgetown University) $43,000


  • Biomarkers/BBB Impact and Whole Exome Genetics (Dr. D. Agalliu & Dr. T. Cutforth, Columbia) $50,000
  • MRI Research (Dr. K. Williams, MGH PANDAS Clinic) $30,000


  • CSF/T17 Findings (Dr. W. Vargas, Columbia) $25,000
  • General Investigation Use (Dr. D. Agalliu & Dr. T. Cutforth, Columbia) $7,000


  • Gene Samples of PANDAS/SC Children (Dr. T. Cutforth, Columbia) $7,000


  • MRI Research (Dr. K. Williams, MGH PANDAS Clinic) $30,000
  • Investigating Epigenetics in PANDAS Children (Dr. T. Murphy, University of S. Florida) $40,000


  • Investigating Rituximab in Severely Ill PANDAS Children (Dr. B. Latimer, Georgetown) $5,000
  • Investigating Virulent Strep in Specified Areas (Dr. J. Frankovich, Stanford) $2,500
  • Immune Dysregulation Research (Dr. T. Murphy, USF) $4,000


  • PANS Research Project Using Cunningham Panel (Dr. M. Cooperstock, University of Missouri) $10,000


  • Tonsil & Adenoid Microbiome Analysis Study (Dr. L. Latimer & Dr. K. Harley, Georgetown) $5,000


  • JCAP Articles Characterization of PANS Children (Dr. Whitty, Dr. Tona, Dr. Murphy, Dr. Doran, University of Buffalo & USF) $3,000

Directors and Scientific Advisors

Our medical clinical advisors are a carefully vetted group of highly recognized clinicians treating PANDAS/PANS. The group’s areas of expertise represent the varying physical and psychological aspects of the disorder. The advisors work together to achieve the common goal of improving the treatment and understanding of PANDAS/PANS. The role of the MCAB is not to give medical advice.


View our latest financial reports.

Our Partners and Affiliates